ALEXANDRIA, Va., June 4 -- United States Patent no. 12,319,658, issued on June 3, was assigned to Eli Lilly and Co. (Indianapolis).
"Pyrimidine-5-carboxamide compound" was invented by Sra. Gema Ruano Plaza (Alcobendas, Spain).
According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention provides a compound of the formula: or a pharmaceutically acceptable salt thereof, and methods of using this compound for treating type 2 diabetes mellitus."
The patent was filed on July 31, 2020, under Application No. 17/631,672.
*For further information, including images, charts and tables, please visit: http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&...